Additionally, a review of 1,494 patients found significant improvements in general psychopathology and positive symptoms, particularly in severely ill patients receiving EPA at doses greater than 1 g/day, along with favorable effects on metabolic parameters such as serum triglycerides (247)
Semaglutide is the most widely prescribed GLP-1 agonist, with an extensive evidence base spanning diabetes, obesity, and cardiovascular outcomes
Interestingly, UCP2 has a dual function of protecting against ROS and supporting fatty acid oxidation [153, 154] and also presents anti-inflammatory effects by having a protective role in acute and chronic neurodegeneration and inflammatory brain diseases [166]
The likely reasons include weight loss, less fluid retention, and better blood vessel function
This is the same classification level required for commercial pharmaceutical manufacturing, not just compounding